{"id":"https://openalex.org/W7085643854","doi":"https://doi.org/10.30476/mejc.2024.103586.2143","title":"Management of HER2-Low Metastatic Breast Cancer: A Comprehensive Statement by an Expert Group from the Middle East and Africa Region","display_name":"Management of HER2-Low Metastatic Breast Cancer: A Comprehensive Statement by an Expert Group from the Middle East and Africa Region","publication_year":2025,"publication_date":"2025-10-01","ids":{"openalex":"https://openalex.org/W7085643854","doi":"https://doi.org/10.30476/mejc.2024.103586.2143"},"language":"en","primary_location":{"id":"pmh:oai:doaj.org/article:cee8bef0df604a8ba57cbc59a00a34cb","doi":"https://doi.org/10.30476/mejc.2024.103586.2143","is_oa":true,"landing_page_url":"https://doaj.org/article/cee8bef0df604a8ba57cbc59a00a34cb","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Middle East Journal of Cancer, Vol 16, Iss 4, Pp 299-321 (2025)","raw_type":"article"},"volume":null,"type":"article","indexed_in":["doaj"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://doaj.org/article/cee8bef0df604a8ba57cbc59a00a34cb","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5046206676","display_name":"Shaheenah S. Dawood","orcid":"https://orcid.org/0000-0001-7665-0059","observed_orcids":["https://orcid.org/0000-0001-7665-0059","https://orcid.org/0000-0002-2662-6904"]},"institutions":[{"id":"https://openalex.org/I4210126093","display_name":"Mediclinic City Hospital","ror":"https://ror.org/041z54681","country_code":"AE","type":"healthcare","lineage":["https://openalex.org/I4210126093"]}],"countries":["AE"],"is_corresponding":false,"raw_author_name":"Shaheenah Dawood","raw_affiliation_strings":["Department of Oncology, Mediclinic Hospital, Dubai, United Arab Emirates"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, Mediclinic Hospital, Dubai, United Arab Emirates","institution_ids":["https://openalex.org/I4210126093"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114101864","display_name":"Mohsen Mokhtar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I145487455","display_name":"Cairo University","ror":"https://ror.org/03q21mh05","country_code":"EG","type":"education","lineage":["https://openalex.org/I145487455"]}],"countries":["EG"],"is_corresponding":false,"raw_author_name":"Mohsen Mokhtar","raw_affiliation_strings":["Department of Oncology, Cairo University, Cairo, Egypt"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, Cairo University, Cairo, Egypt","institution_ids":["https://openalex.org/I145487455"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076277084","display_name":"Ahmed M. Alwbari","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ahmed Alwbari","raw_affiliation_strings":["Department of Oncology, Almoosa Specialist Hospital, Oncology Center, Al Mubarraz, Saudi Arabia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, Almoosa Specialist Hospital, Oncology Center, Al Mubarraz, Saudi Arabia","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Bernardo Rapoport","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210089752","display_name":"The Medical Oncology Centre of Rosebank","ror":"https://ror.org/00cpjch55","country_code":"ZA","type":"healthcare","lineage":["https://openalex.org/I4210089752"]}],"countries":["ZA"],"is_corresponding":false,"raw_author_name":"Bernardo Rapoport","raw_affiliation_strings":["The Medical Oncology Centre of Rosebank, Johannesburg, South Africa"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Medical Oncology Centre of Rosebank, Johannesburg, South Africa","institution_ids":["https://openalex.org/I4210089752"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067087846","display_name":"Ece Esin","orcid":"https://orcid.org/0000-0002-7073-9906","observed_orcids":["https://orcid.org/0000-0002-7073-9906"]},"institutions":[{"id":"https://openalex.org/I4210089555","display_name":"Bay\u0131nd\u0131r Hastanesi","ror":"https://ror.org/0084g8g60","country_code":"TR","type":"healthcare","lineage":["https://openalex.org/I4210089555"]}],"countries":["TR"],"is_corresponding":false,"raw_author_name":"Ece Esin","raw_affiliation_strings":["Department of Medical Oncology, Bayindir Hospital, Ankara, Turkey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Bayindir Hospital, Ankara, Turkey","institution_ids":["https://openalex.org/I4210089555"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Hassan Jaafar","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hassan Jaafar","raw_affiliation_strings":["Department of Oncology, Sheikh Khalifa Specialty Hospital, Abu Dhabi, United Arab Emirates"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, Sheikh Khalifa Specialty Hospital, Abu Dhabi, United Arab Emirates","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Jamal Zekri","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210154214","display_name":"Royal Preston Hospital","ror":"https://ror.org/05kpx1157","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1293129422","https://openalex.org/I4210154214"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Jamal Zekri","raw_affiliation_strings":["Department of Oncology, Royal Preston Hospital, Sharoe Green Lane, Fulwood, Preston, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, Royal Preston Hospital, Sharoe Green Lane, Fulwood, Preston, United Kingdom","institution_ids":["https://openalex.org/I4210154214"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111609687","display_name":"Narjiss Berrada","orcid":"https://orcid.org/0000-0003-4291-0873","observed_orcids":["https://orcid.org/0000-0003-4291-0873"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Narjiss Berrada","raw_affiliation_strings":["Department of Oncology, Chellah University, Rabat, Morocco"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, Chellah University, Rabat, Morocco","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030366726","display_name":"\u00d6zg\u00fcr \u00d6zy\u0131lkan","orcid":"https://orcid.org/0000-0001-8825-4918","observed_orcids":["https://orcid.org/0000-0001-8825-4918"]},"institutions":[{"id":"https://openalex.org/I188740104","display_name":"Ba\u015fkent University","ror":"https://ror.org/02v9bqx10","country_code":"TR","type":"education","lineage":["https://openalex.org/I188740104"]}],"countries":["TR"],"is_corresponding":false,"raw_author_name":"Ozgur Ozyilkan","raw_affiliation_strings":["Department of Oncology, Baskent University, Ankara, Turkey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, Baskent University, Ankara, Turkey","institution_ids":["https://openalex.org/I188740104"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5047724065","display_name":"Nagi S. El Saghir","orcid":"https://orcid.org/0000-0001-9612-4224","observed_orcids":["https://orcid.org/0000-0001-9612-4224"]},"institutions":[{"id":"https://openalex.org/I4210104580","display_name":"American University of Beirut Medical Center","ror":"https://ror.org/00wmm6v75","country_code":"LB","type":"healthcare","lineage":["https://openalex.org/I4210104580"]},{"id":"https://openalex.org/I98635879","display_name":"American University of Beirut","ror":"https://ror.org/04pznsd21","country_code":"LB","type":"education","lineage":["https://openalex.org/I98635879"]}],"countries":["LB"],"is_corresponding":false,"raw_author_name":"Nagi El Saghir","raw_affiliation_strings":["Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon","institution_ids":["https://openalex.org/I4210104580","https://openalex.org/I98635879"]}]}],"institutions":[],"countries_distinct_count":6,"institutions_distinct_count":8,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.43359639,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":true,"primary_topic":{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9564999938011169,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9564999938011169,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.02969999983906746,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.004600000102072954,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/her2-low-breast-cancer","display_name":"HER2-low breast cancer","score":0.9919999837875366},{"id":"https://openalex.org/keywords/metastatic-breast-cancer","display_name":"metastatic breast cancer","score":0.9940000176429749},{"id":"https://openalex.org/keywords/trastuzumab-deruxtecan","display_name":"trastuzumab deruxtecan","score":0.9190000295639038},{"id":"https://openalex.org/keywords/antibody-drug-conjugates","display_name":"antibody-drug conjugates","score":0.875},{"id":"https://openalex.org/keywords/cdk4-6-inhibitors","display_name":"CDK4/6 inhibitors","score":0.9049999713897705},{"id":"https://openalex.org/keywords/pi3k-inhibitors","display_name":"PI3K inhibitors","score":0.9350000023841858},{"id":"https://openalex.org/keywords/parp-inhibitors","display_name":"PARP inhibitors","score":0.9990000128746033},{"id":"https://openalex.org/keywords/pd-l1-inhibitors","display_name":"PD-L1 inhibitors","score":0.9459999799728394},{"id":"https://openalex.org/keywords/treatment-sequencing","display_name":"treatment sequencing","score":0.9129999876022339},{"id":"https://openalex.org/keywords/clinical-guidelines","display_name":"clinical guidelines","score":0.546999990940094},{"id":"https://openalex.org/keywords/middle-east-and-africa","display_name":"Middle East and Africa","score":0.9760000109672546}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8296999931335449},{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.784500002861023},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.636900007724762},{"id":"https://openalex.org/C2908728163","wikidata":"https://www.wikidata.org/wiki/Q415271","display_name":"Human Epidermal Growth Factor Receptor 2","level":4,"score":0.5321999788284302},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5095000267028809},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.5077999830245972},{"id":"https://openalex.org/C2777026412","wikidata":"https://www.wikidata.org/wiki/Q2684591","display_name":"Statement (logic)","level":2,"score":0.4690999984741211},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.421099990606308},{"id":"https://openalex.org/C29456083","wikidata":"https://www.wikidata.org/wiki/Q1221899","display_name":"Gynecology","level":1,"score":0.4174000024795532},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.40869998931884766},{"id":"https://openalex.org/C3651065","wikidata":"https://www.wikidata.org/wiki/Q7204","display_name":"Middle East","level":2,"score":0.38679999113082886},{"id":"https://openalex.org/C2776598537","wikidata":"https://www.wikidata.org/wiki/Q1812651","display_name":"Clinical Oncology","level":3,"score":0.3718999922275543},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3634999990463257},{"id":"https://openalex.org/C185926286","wikidata":"https://www.wikidata.org/wiki/Q1929812","display_name":"Systemic therapy","level":4,"score":0.35530000925064087},{"id":"https://openalex.org/C2781230642","wikidata":"https://www.wikidata.org/wiki/Q492646","display_name":"Targeted therapy","level":3,"score":0.3456999957561493},{"id":"https://openalex.org/C2780182762","wikidata":"https://www.wikidata.org/wiki/Q1630279","display_name":"Guideline","level":2,"score":0.3416999876499176},{"id":"https://openalex.org/C2777329042","wikidata":"https://www.wikidata.org/wiki/Q420323","display_name":"Lapatinib","level":5,"score":0.3305000066757202},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.31450000405311584},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.31360000371932983},{"id":"https://openalex.org/C2779974597","wikidata":"https://www.wikidata.org/wiki/Q28448986","display_name":"Clinical Practice","level":2,"score":0.30820000171661377},{"id":"https://openalex.org/C2993769353","wikidata":"https://www.wikidata.org/wiki/Q7598360","display_name":"Standard of care","level":2,"score":0.30000001192092896},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.26179999113082886}],"mesh":[],"locations_count":1,"locations":[{"id":"pmh:oai:doaj.org/article:cee8bef0df604a8ba57cbc59a00a34cb","doi":"https://doi.org/10.30476/mejc.2024.103586.2143","is_oa":true,"landing_page_url":"https://doaj.org/article/cee8bef0df604a8ba57cbc59a00a34cb","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Middle East Journal of Cancer, Vol 16, Iss 4, Pp 299-321 (2025)","raw_type":"article"}],"best_oa_location":{"id":"pmh:oai:doaj.org/article:cee8bef0df604a8ba57cbc59a00a34cb","doi":"https://doi.org/10.30476/mejc.2024.103586.2143","is_oa":true,"landing_page_url":"https://doaj.org/article/cee8bef0df604a8ba57cbc59a00a34cb","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Middle East Journal of Cancer, Vol 16, Iss 4, Pp 299-321 (2025)","raw_type":"article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/16","display_name":"Peace, justice, and strong institutions","score":0.47308069467544556}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":[],"abstract_inverted_index":{"Approximately":[0],"50":[1],"to":[2,120,129],"67%":[3],"of":[4,35,100,137],"breast":[5],"cancers":[6],"(BCs),":[7],"traditionally":[8],"categorized":[9],"as":[10,27,48,87,133,135],"human":[11],"epidermal":[12],"growth":[13],"factor":[14],"receptor":[15],"2":[16],"(HER2)-negative,":[17],"but":[18],"demonstrating":[19],"low":[20],"HER2":[21,131],"expression,":[22],"are":[23],"now":[24],"being":[25],"defined":[26],"a":[28],"new":[29],"HER2-low":[30,33],"subset":[31],"or":[32],"category":[34],"BC.":[36],"For":[37],"metastatic":[38],"BC":[39],"(mBC),":[40],"standard":[41],"therapy":[42],"options":[43,95],"include":[44],"targeted":[45],"approaches,":[46],"such":[47,86],"cyclin-dependent":[49],"kinase":[50],"4/6":[51],"inhibitors,":[52,55,60],"phosphoinositide":[53],"3-kinase":[54],"poly":[56],"(adenosine":[57],"diphosphate-ribose)":[58],"polymerase":[59],"and":[61,70,126,146],"anti-programmed":[62],"death-ligand":[63],"1":[64],"agents,":[65],"depending":[66],"on":[67],"tumor":[68],"type":[69],"its":[71],"molecular":[72],"profile.":[73],"Recent":[74],"clinical":[75,79,102,111],"trials":[76],"reported":[77],"significant":[78],"benefits":[80],"from":[81],"novel":[82],"anti\u2011HER2":[83],"antibody\u2011drug":[84],"conjugates,":[85],"trastuzumab":[88],"deruxtecan":[89],"in":[90,142],"HER2\u2011low":[91,140],"mBC.":[92],"Novel":[93],"treatment":[94,107,136],"have":[96],"increased":[97],"the":[98,101,122,143],"complexity":[99],"decision\u2011making":[103],"process,":[104],"particularly":[105],"for":[106,109],"sequencing":[108],"each":[110],"setting.":[112],"A":[113],"regional":[114],"expert":[115],"committee":[116],"meeting":[117],"was":[118],"held":[119],"discuss":[121],"challenges,":[123],"overcome":[124],"limitations,":[125],"present":[127],"recommendations":[128],"enhance":[130],"reporting":[132],"well":[134],"patients":[138],"with":[139],"mBC":[141],"Middle":[144],"East":[145],"Africa":[147],"region.":[148]},"counts_by_year":[],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2025-10-10T00:00:00"}